Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02432456 · ClinicalTrials.gov registry record · Phase 4
Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients
A Phase 4 study of Wounds and Injuries and Rib Fractures, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 4
- Development phase
- 153
- Enrollment target
- 1
- Study location
NCT02432456: Completed Phase 4 study of Wounds and Injuries and Rib Fractures, sponsored by Medical College of Wisconsin.
NCT02432456 is a Phase 4 study of Wounds and Injuries and Rib Fractures that has completed, run by Medical College of Wisconsin. The registered enrollment target is 153 participants, below the 498-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02432456, a Phase 4 study of Wounds and Injuries and Rib Fractures, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 153 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of ketamine infusions in the management of acute pain resulting from broken ribs suffered following a blunt trauma. Half of patients will receive the institutional standard of care and a placebo infusion (no active medication). The other half of patients will receive the institutional standard of care and a ketamine infusion. All subjects and staff will be blinded as to whether they are receiving placebo or ketamine.
Primary Outcome
Visual Analog Numeric Pain scores are reported as a single numeric score between 0 and 10. The more severe the pain the higher the number with 10 representing the most severe pain imaginable.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Acetaminophen
- DRUG Ketamine
- DRUG Ibuprofen
- PROCEDURE Intercostal Nerve Block
Study Locations (1)
Wisconsin
- Froedtert Memorial Lutheran Hospital - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2015-09 |
| Est. Completion | 2018-08 |
| Phase | Phase 4 |
What the finished NCT02432456 record still lists
NCT02432456 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 498-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (69% lower).
The record links to 2 conditions, with Wounds and Injuries appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT02432456 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT02432456 about?
NCT02432456 is a clinical study titled "Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients". This study will evaluate the effectiveness of ketamine infusions in the management of acute pain resulting from broken ribs suffered following a blunt trauma. Half of patients will receive the institutional standard of care and a placebo infusion (no active medication). The other half of patients wi...
What is the current status of trial NCT02432456?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 153 participants. The study started on 2015-09. Estimated completion is 2018-08.
What conditions does trial NCT02432456 study?
This clinical trial studies the following conditions: Wounds and Injuries, Rib Fractures.
What interventions are being tested in trial NCT02432456?
The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG), Ketamine (DRUG), Ibuprofen (DRUG), Intercostal Nerve Block (PROCEDURE).
Who is sponsoring clinical trial NCT02432456?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02432456 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wounds and Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02432456's enrollment target sits among peer trials
153 16th of 27 higher than 12 of 27 other Wounds and Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wounds and Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing
RECRUITING · Phase 4
-
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
RECRUITING · Phase 3
-
Effect of Giving Reduced Fluid in Children After Trauma
RECRUITING · NA
-
Blood Flow Restriction Training After Patellar INStability
RECRUITING · NA
-
Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness
RECRUITING · NA
-
Pediatric Prehospital Airway Resuscitation Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia